Compared with the SCH group, the expression of p-TrkA and p-CREB increased significantly in L-T4 treatment from E10 and E13 (p < 0.05), and three L-T4 treatment groups p-ERK1/2 were increased significantly (p < 0.05). The gene discussed is NTRK1; the disease is spindle cell hemangioma.